Merck & Co. Inc. (MRK)
79.13
1.58 (2.04%)
At close: Apr 11, 2025, 3:59 PM
79.10
-0.04%
After-hours: Apr 11, 2025, 05:58 PM EDT
2.04% (1D)
| Bid | 78.44 |
| Market Cap | 199.89B |
| Revenue (ttm) | 64.17B |
| Net Income (ttm) | 17.12B |
| EPS (ttm) | 6.74 |
| PE Ratio (ttm) | 11.74 |
| Forward PE | 10.49 |
| Analyst | Buy |
| Ask | 79.08 |
| Volume | 13,001,132 |
| Avg. Volume (20D) | 17,710,797 |
| Open | 77.85 |
| Previous Close | 77.55 |
| Day's Range | 76.36 - 79.44 |
| 52-Week Range | 75.96 - 134.63 |
| Beta | 0.42 |
About MRK
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Jan 13, 1978
Employees 73,000
Stock Exchange NYSE
Ticker Symbol MRK
Website https://www.merck.com
Analyst Forecast
According to 13 analyst ratings, the average rating for MRK stock is "Buy." The 12-month stock price forecast is $111, which is an increase of 40.28% from the latest price.
Stock ForecastsNext Earnings Release
Merck & Co. Inc. is scheduled to release its earnings on Apr 24, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-4.81%
Merck & Company shares are trading lower. The comp...
Unlock content with
Pro Subscription
2 months ago
-9.07%
Merck shares are trading lower after the company issued 2025 sales guidance below analyst estimates.
